GENZ Biotech; It is an R&D company operating in the field of biotechnology, serving the health of the society, established to make DNA analysis more accessible to the society. As a natural result of the R&D activities we carry out, we are developing gene screening in vitro diagnostic kits that are both efficient and low-cost and most importantly, suitable for the gene pool of the Turkish society. The first product of the GENZ Biotech portfolio, Breast Cancer Risk Panel, was launched at the end of 2018. Our difference is that we develop a DNA screening test that determines general and regional genetic factors based on the Turkish and Middle Eastern society with common genetic heritage. In line with our goal, our work continues with care and at full speed.
B2C, B2B
1 to 25
Funded
$584,616
Scaling Up
2017
Computer Software
Biotechnology
Application Software
N/A
N/A
N/A
Yes
Active
Machine Learning
Machine Perception
Natural Language Processing
N/A
Software
Potential Customers
Interested in what they do or partnership?
Learn more about how they work